Superficial surgical-site infection (sSSI) in elective oncological and non-oncological hepatobiliary and pancreatic surgery Surgery
Conditions
Interventions
Fascial closure will be performed according to the most recent evidence in order to minimize the risk of dehiscence and fascial site infection. For fascial closure continuous suture with synthetic abs
Sponsors
Hospital Universitario Donostia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients undergoing elective oncological and non-oncological hepatobiliary and/or pancreatic surgery that have approved and signed the informed consent document
Exclusion criteria
Exclusion criteria: 1. Emergency surgery 2. Contaminated surgery according to WHO criteria and CDC definition for surgery 3. Active intraabdominal infectious process at the time of the surgery 4. Requirement for re-intervention due to a major postoperative intraabdominal complication 5. Non-compliance of the previously defined and standardized skin closure protocol including WHO recommendations for prevention of surgical site infection 6. Patients declined to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sSSI rate measured by review of clinical records (i.e. medical history, daily medical records, complementary tests such as microbiological wound tests) at 30 days of follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Incidence of sSSI measured using clinical records at 30 days of follow-up 2. Risk factors associated with sSSI measured using review of medical records, including baseline characteristics, previous medical background and variables related to the surgical procedure, at 30 days of follow-up 3. Hospital admission days measured using medical records at 30 days of follow-up | — |
Countries
Spain
Outcome results
None listed